Psyched Wellness Adds Amanita Muscaria Expert To Advisory Board

Kevin Feeney has joined the advisory board of that of Psyched Wellness (CSE: PSYC) as of this morning. Feeney will be working with the company to identify novel uses for the psychoactive constituent in Amanita Muscaria, which is known as Muscimol.

Feeny is a cultural anthropologist and lawyer, whom current serves as program director as well as an instructor in interdisciplinary studies – social sciences at the Central Washington University. Viewed as an expert on the Amanita muscaria mushroom, his primary research is focused on examining legal and regulatory issues that surround psychoactive substances, as well as exploring both the modern and traditional uses of these unique species of mushrooms.

Furthermore, Feeney, whom has a PhD in cultural anthropology, has many publications to his name, including an edited volume on amanita muscaria within Fly Agaric: A Compendium of History, Pharmacology, Mythology, and Exploration, while having also been published in the Journal of Psychoactive Drugs and the International Journal of Drug Policy among others.

Emerita Resources Corp. — sponsored Sponsored · Emerita Resources Corp.

Commenting on his appointed as scientific advisor to Psyched Wellness, Feeney stated, “Amanita Muscaria has a long history of use for treating a number of ailments including anxiety, insomnia, pain, and inflammation. While this mushroom has been largely overlooked in both standard and alternative medicines, its potential applications are rich and largely unexplored, and shows promise in such disparate areas as treating alcohol and benzodiazepine withdrawal as well as alleviating cognitive impairments related to Lyme disease and Alzheimer’s.”

The addition to the board of advisors is seen as being a key development within the growth of the company. The experience brought forth by Feeny is expected to assist the company in identifying new novel uses of the compound, in applications for health and wellness.

Psyched Wellness last traded at $0.195 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Trending

Related News

Psyched Wellness Submits Trademark For Amanita Muscaria Extract

Psyched Wellness (CSE: PSYC) is looking to build up its portfolio of intellectual property. The...

Thursday, January 21, 2021, 07:01:48 AM

Psyched Wellness Files Patent Application For Proprietary AME-1 Extraction Process

Psyched Wellness (CSE: PSYC) has begun the process of protecting its intellectual property. The firm...

Wednesday, March 17, 2021, 07:32:20 AM

Psyched Wellness: Canaccord Pens “Future In Fungi Report”

Yesterday morning, Canaccord Genuity released a primer into five psychedelic companies that they “believe could...

Tuesday, March 9, 2021, 11:49:00 AM

Psyched Wellness Sees Positive Initial Results From AME-1 Extract Study

Psyched Wellness (CSE: PSYC) this morning provided an update on its study to determine the...

Thursday, February 4, 2021, 07:33:40 AM

David Nutt: Amanita Muscaria Due For More Research – The Daily Dive

Today on the Daily Dive, our host Cassandra Leah sits down with Dr David Nutt,...

Wednesday, March 10, 2021, 01:30:00 PM